FEB 27, 2022 6:02 AM PST

Blood-Brain Barrier Damage is Linked to Disease But Might be Fixable

WRITTEN BY: Carmen Leitch

The blood-brain barrier is a unique membrane that shields the central nervous system from harm. This physiological barrier is formed by a network of cells and blood vessels that carefully regulates the passage of molecules, cells, and materials between circulating blood and the brain. A variety of brain disorders have been associated with defects in that network. Researchers have now developed a novel type of drug that seems to repair those defects. In mouse models, these therapeutics effectively reduced lesions that occur in the brain after a stroke, and reduced the progression of glioblastoma, a common type of brain cancer.

Image credit: modified from Pixabay/geralt

In recent work reported in Science, researchers led by Professor Benoit Vanhollebeke of the Free University of Brussels (ULB) studied molecules that are involved in the development of the blood brain barrier. They theorized that some of these molecules could help repair blood-brain barrier damage. The team found that a signaling protein called Wnt7a/b, which can act on a variety of biochemical pathways, could impact the blood-brain barrier through a membrane complex called Gpr124/Reck (G protein–coupled receptor Gpr124 and the glycosylphosphatidylinositol-anchored glycoprotein Reck).

The researchers tested molecules that can activate Gpr124/Reck in various models, and found that they were well-tolerated. The drugs were also able to help restore function to blood vessels that had become too permeable. The integrity of the blood brain barrier was also boosted by Gpr124/Reck agonists; molecular and cellular features that demonstrate a strict regulation of how materials are exchanged were observed. In animal models, the drugs helped strengthen the blood brain barrier and slow the progression of various disease states.

These drugs were found to act in a very selective way, noted the researchers. "One of the most fascinating aspects of this study is the level of specificity with which pathological brain vessels respond to this experimental treatment," said Vanhollebeke.

As they engineered this "new class of molecules," the scientists were "inspired by the natural developmental process. The drugs they created "are able to reach their therapeutic target efficiently," and left other healthy tissues in the body unperturbed. "On a fundamental basis, this level of specificity seemed a priori out of reach," added Vanhollebeke.

Now, the researchers want to find out whether these drugs can help treat other brain disorders as well. Vanhollebeke and the ULB have also founded a company NeuVasQ Biotechnologies to bring together public and private investors, and take this neurovascular treatment to the clinic.

Sources: Université libre de Bruxelles (ULB), Science

About the Author
BS
Experienced research scientist and technical expert with authorships on over 30 peer-reviewed publications, traveler to over 70 countries, published photographer and internationally-exhibited painter, volunteer trained in disaster-response, CPR and DV counseling.
You May Also Like
APR 21, 2022
Cardiology
Physical Activity Improves Memory Function
APR 21, 2022
Physical Activity Improves Memory Function
Just 10 minutes of mild exercise immediately improves brain connectivity.
APR 21, 2022
Health & Medicine
Inhibiting a Key Signaling Pathway in Immune Cells Slows Alzheimer's Progression
APR 21, 2022
Inhibiting a Key Signaling Pathway in Immune Cells Slows Alzheimer's Progression
Weill Cornell Medicine researchers recently discovered that inhibiting a key signaling pathway in brain cells can lessen ...
APR 21, 2022
Drug Discovery & Development
No Link Between Antidepressants and Improved Quality of Life
APR 21, 2022
No Link Between Antidepressants and Improved Quality of Life
Those who use antidepressant medications have a similar health-related quality of life to people who are depressed and w ...
MAY 09, 2022
Neuroscience
Can Gene Therapy Treat Psychiatric Disorders?
MAY 09, 2022
Can Gene Therapy Treat Psychiatric Disorders?
Using cutting-edge technologies, researchers have shown how mutations in a gene called Transcription Factor 4 (TCF4) can ...
MAY 09, 2022
Health & Medicine
How Adult Acne Affects Women
MAY 09, 2022
How Adult Acne Affects Women
Although commonly thought of as a disease of adolescence, acne is said to affect nearly 50% of women in their 20s and ne ...
MAY 16, 2022
Clinical & Molecular DX
Trial Underway for Alzheimer's Vaccine
MAY 16, 2022
Trial Underway for Alzheimer's Vaccine
Almost twenty years ago, researchers at the Ann Romney Center at Brigham and Women’s Hospital began researching th ...
Loading Comments...